Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Improving Translational Accuracy

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...

Improving Translational Accuracy

Improving Translational Accuracy

Translational Regulation

Translational Regulation

Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...

Leaky Scanning

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...

Cotranslational Protein Translocation

Cotranslational Protein Translocation

Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...

Ribosome Profiling

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Botulinum Toxin Type A Injections in the Bladder Wall-An Effective Treatment for Urinary Incontinence with Low Long-Term Adherence.

Toxins·2026

Same author

Letter regarding Pini, A., Nardini, P., Zizi, V., Molino, M., Calvani, M., Carrozzo, F., … Filippi, L. (2026). β3-adrenoceptor agonism exerts lung protection in a rat model of bronchopulmonary dysplasia. Br J Pharmacol, in press.

British journal of pharmacology·2026

Same author

A year in pharmacology: new drugs approved by the US food and drug administration in 2025.

Naunyn-Schmiedeberg's archives of pharmacology·2026

Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025

Same author

Correction to: Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes.

World journal of urology·2025

Same author

Biased Agonism at β-Adrenoceptor Subtypes: A Drug Development Perspective.

Handbook of experimental pharmacology·2025

Search research articles

Related Experiment Video

Updated: Jan 6, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Building Robustness into Translational Research.

Betül R Erdogan¹, Martin C Michel²

¹Department of Pharmacology, School of Pharmacy, Ankara University, Ankara, Turkey.

Handbook of Experimental Pharmacology

|October 11, 2019

Summary

This summary is machine-generated.

Preclinical studies require careful design to ensure therapeutic candidates translate to human patients. Incorporating animal model heterogeneity and addressing potential biases are crucial for ethical and economic success in drug development.

Keywords:

Age Comorbidity Heterogeneity Robustness Sex Translational research

More Related Videos

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

Rapid In Vivo Fixation and Isolation of Translational Complexes from Eukaryotic Cells

Rapid In Vivo Fixation and Isolation of Translational Complexes from Eukaryotic Cells

Published on: December 25, 2021

Related Experiment Videos

Last Updated: Jan 6, 2026

Quantitative Immunofluorescence to Measure Global Localized Translation

Quantitative Immunofluorescence to Measure Global Localized Translation

Published on: August 22, 2017

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Measurement of Specific Mycobacterial Mistranslation Rates with Gain-of-function Reporter Systems

Published on: April 26, 2019

Rapid In Vivo Fixation and Isolation of Translational Complexes from Eukaryotic Cells

Rapid In Vivo Fixation and Isolation of Translational Complexes from Eukaryotic Cells

Published on: December 25, 2021

Area of Science:

Preclinical research
Translational science
Drug development

Background:

Nonclinical studies are foundational for advancing therapeutic candidates to clinical trials.
Ensuring translational robustness in these studies is vital for ethical and economic considerations.
Heterogeneity in patient populations necessitates reflection in preclinical study designs.

Purpose of the Study:

To highlight the importance of translational robustness in nonclinical studies.
To identify key factors influencing the predictive value of preclinical research for human outcomes.
To emphasize the need for careful consideration of biases in translational studies.

Main Methods:

Review of principles for designing robust preclinical studies.
Analysis of factors contributing to translational success or failure.
Discussion of sources of bias specific to translational research.

Main Results:

Findings confirmed across multiple species increase the likelihood of human relevance.
Incorporating heterogeneity (e.g., animal strains, sex, age, comorbidities) enhances model translatability but requires larger sample sizes.
Potential biases include model limitations, treatment timing, dosing, and pharmacokinetic differences.

Conclusions:

Translational robustness in nonclinical studies is paramount for successful drug development.
Preclinical study designs must account for biological variability and potential biases.
A balanced approach considering all factors is essential for each study and program.